(Q50117999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

R Norda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

O Berséus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

33-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic apheresis in hematological and oncological diseases

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Spin doctors: new innovations for centrifugal apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Frequency of immediate adverse effects associated with apheresis donation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Frequency of immediate adverse effects associated with therapeutic apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Introduction to the third special issue: clinical applications of therapeutic apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

The Canadian Apheresis Group and therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Plasmapheresis in the treatment of glomerulonephritis: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Severe infections in plasmapheresis-treated systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Clinically relevant hypokalaemia, hypocalcaemia, and loss of hemoglobin and platelets during stem cell apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Apheresis registry in France: indications, techniques, and complications. French Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Therapeutic plasma exchange: an update from the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Three years with a national apheresis registry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

National survey of hemapheresis practice in Turkey (1998).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Present status of therapeutic apheresis in Japan: survey report. (Survey Subcommittee, Scientific Committee, Japanese Society for Apheresis).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Complications of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Apheresis and ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

Safety of plasmapheresis in the treatment of neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900079-9

7 January 2021

10.1016/S1473-0502(01)00079-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791760%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference